BOLT vs MTCH · rev $7.7M vs P/E 13, rev $3.48B
Bolt Biotherapeutics (BOLT) versus Match Group Inc (MTCH) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported MTCH revenue for 2024-12-31 was $3.48B. Net income was $551.3M. Revenue was up 3.4% from 2023-12-31 to 2024-12-31. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
BOLT currently screens at market cap $11.3M. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Not investment advice. Open the BOLT and MTCH stock pages for the full models.
Not investment advice.